Microbial Drug Resistance
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.8 | Q3 | 27.8% | 0.605 | Q2 | 67.9% |
| 2024 | 1.9 | Q3 | 32.9% | 0.627 | Q2 | 69.9% |
| 2023 | 2.3 | Q3 | 45.6% | 0.596 | Q2 | 70.7% |
| 2022 | 2.6 | Q3 | 44.3% | 0.589 | Q2 | 71.4% |
| 2021 | 2.7 | Q3 | 46.3% | 0.648 | Q2 | 75.2% |
| 2020 | — | — | 0.889 | Q2 | 82.5% | |
| 2019 | — | — | 0.881 | Q1 | 82.7% | |
| 2018 | — | — | 0.946 | Q1 | 82.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1931-8448
ISSN
1076-6294
region
Northern America
coverage
1995-2026